Clinical trial update: International Breast Cancer Study Group

por Price, Karen N, Goldhirsch, Aron
Publicado 2005

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease

por Goldhirsch, Aron, Colleoni, Marco, Regan, Meredith
Publicado 2015

Different effectiveness of anticancer immunotherapy in men and women relies on sex-dimorphism of the immune system

por Conforti, Fabio, Pala, Laura, Goldhirsch, Aron
Publicado 2018

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date

por Criscitiello, Carmen, Viale, Giulia, Curigliano, Giuseppe, Goldhirsch, Aron
Publicado 2018

Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”

por Gelao, Lucia, Criscitiello, Carmen, Esposito, Angela, Goldhirsch, Aron, Curigliano, Giuseppe
Publicado 2014

The 6th Milan Breast Cancer Conference, Milan, Italy, 16–18 June 2004

por Gennari, Roberto, Cinieri, Saverio, Colleoni, Marco, Zurrida, Stefano, Goldhirsch, Aron, Veronesi, Umberto
Publicado 2005

Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

por Munzone, Elisabetta, Curigliano, Giuseppe, Rocca, Andrea, Bonizzi, Giuseppina, Renne, Giuseppe, Goldhirsch, Aron, Nolè, Franco
Publicado 2006

Correction: Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

por Munzone, Elisabetta, Curigliano, Giuseppe, Rocca, Andrea, Bonizzi, Giuseppina, Renne, Giuseppe, Goldhirsch, Aron, Nolè, Franco
Publicado 2006

International Web-based consultation on priorities for translational breast cancer research

por Dowsett, Mitch, Goldhirsch, Aron, Hayes, Daniel F, Senn, Hans-Joerg, Wood, William, Viale, Giuseppe
Publicado 2007

Best management of locally advanced inoperable breast cancer

por Curigliano, Giuseppe, Criscitiello, Carmen, Esposito, Angela, Fumagalli, Luca, Gelao, Lucia, Locatelli, Marzia, Minchella, Ida, Goldhirsch, Aron
Publicado 2013

Immune approaches to the treatment of breast cancer, around the corner?

por Criscitiello, Carmen, Esposito, Angela, Gelao, Lucia, Fumagalli, Luca, Locatelli, Marzia, Minchella, Ida, Adamoli, Laura, Goldhirsch, Aron, Curigliano, Giuseppe
Publicado 2014

Impact of autoimmune diseases on outcome of patients with early breast cancer

por Criscitiello, Carmen, Bagnardi, Vincenzo, Esposito, Angela, Gelao, Lucia, Santillo, Barbara, Viale, Giulia, Rotmensz, Nicole, Goldhirsch, Aron, Curigliano, Giuseppe
Publicado 2016

Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer

por Orlando, Laura, Cardillo, Anna, Ghisini, Raffaella, Rocca, Andrea, Balduzzi, Alessandra, Torrisi, Rosalba, Peruzzotti, Giulia, Goldhirsch, Aron, Pietri, Elisabetta, Colleoni, Marco
Publicado 2006

Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives

por Criscitiello, Carmen, André, Fabrice, Thompson, Alastair M, De Laurentiis, Michele, Esposito, Angela, Gelao, Lucia, Fumagalli, Luca, Locatelli, Marzia, Minchella, Ida, Orsi, Franco, Goldhirsch, Aron, Curigliano, Giuseppe
Publicado 2014

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

por Maisonneuve, Patrick, Disalvatore, Davide, Rotmensz, Nicole, Curigliano, Giuseppe, Colleoni, Marco, Dellapasqua, Silvia, Pruneri, Giancarlo, Mastropasqua, Mauro G, Luini, Alberto, Bassi, Fabio, Pagani, Gianmatteo, Viale, Giuseppe, Goldhirsch, Aron
Publicado 2014

Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data

por Schmid, Sabine, Klingbiel, Dirk, Aebi, Stefan, Goldhirsch, Aron, Mamot, Christoph, Munzone, Elisabetta, Nolè, Franco, Oehlschlegel, Christian, Pagani, Olivia, Pestalozzi, Bernhard, Rochlitz, Christoph, Thürlimann, Beat, von Moos, Roger, Weder, Patrik, Zaman, Khalil, Ruhstaller, Thomas
Publicado 2019

Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence

por Conforti, Fabio, Pala, Laura, Pagan, Eleonora, Viale, Giuseppe, Bagnardi, Vincenzo, Peruzzotti, Giulia, De Pas, Tommaso, Bianco, Nadia, Graffeo, Rossella, Rocco, Elena Guerini, Vingiani, Andrea, Gelber, Richard D., Coates, Alan S., Colleoni, Marco, Goldhirsch, Aron
Publicado 2019

Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX

por Coates, Alan S, Millar, Ewan KA, O'Toole, Sandra A, Molloy, Timothy J, Viale, Giuseppe, Goldhirsch, Aron, Regan, Meredith M, Gelber, Richard D, Sun, Zhuoxin, Castiglione-Gertsch, Monica, Gusterson, Barry, Musgrove, Elizabeth A, Sutherland, Robert L
Publicado 2012

Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT

por Pagani, Olivia, Francis, Prudence A., Fleming, Gini F., Walley, Barbara A., Viale, Giuseppe, Colleoni, Marco, Láng, István, Gómez, Henry L., Tondini, Carlo, Pinotti, Graziella, Di Leo, Angelo, Coates, Alan S., Goldhirsch, Aron, Gelber, Richard D., Regan, Meredith M.
Publicado 2020

Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial

por Johansson, Harriet, Gray, Kathryn P., Pagani, Olivia, Regan, Meredith M., Viale, Giuseppe, Aristarco, Valentina, Macis, Debora, Puccio, Antonella, Roux, Susanne, Maibach, Rudolf, Colleoni, Marco, Rabaglio, Manuela, Price, Karen N., Coates, Alan S., Gelber, Richard D., Goldhirsch, Aron, Kammler, Roswitha, Bonanni, Bernardo, Walley, Barbara A.
Publicado 2016